Olaguoke Akinwande, MD
Vascular & Interventional Radiology · Saint Louis, MONPI 1235362252
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Philips North America LLC at 47.9% of the total. Reporting peaked in 2022 at $8,599 and has fallen 89.5% since, to $906 in 2025.
Across 140 payments — averaging $153.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$10K
- Terumo Medical Corporation$5K
- Siemens Medical Solutions USA, Inc.$3K
- Nevro Corp.$871
- Abbott$686
- Boston Scientific$598
- plus $2K from 16 others
What the payments were for
- Consulting fees$11,63554%
- Speaking & faculty fees$2,40011%
- Travel & lodging$1,4167%
- Food & beverage$6,01328%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 52 | $10,275 |
| Terumo Medical Corporation | 11 | $4,944 |
| Siemens Medical Solutions USA, Inc. | 3 | $2,524 |
| Nevro Corp. | 6 | $871 |
| Abbott | 25 | $686 |
| Boston Scientific | 11 | $598 |
| Cordis US CORP. | 3 | $251 |
| Medtronic(2 entities) | 4 | $229 |
| Bard Peripheral Vascular, Inc. | 3 | $221 |
| Penumbra, Inc. | 1 | $147 |
| Organogenesis Inc. | 3 | $126 |
| Inari Medical, Inc. | 1 | $102 |
| Next Science LLC | 1 | $94 |
| Johnson & Johnson | 5 | $93 |
| Angiodynamics, Inc. | 1 | $84 |
| Cardiovascular Systems Inc. | 3 | $67 |
| Sirtex Medical Inc | 1 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Fisher & Paykel Healthcare Inc | 1 | $22 |
| Avanos Medical | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $15 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IGT Devices Und$3,680
- (9520) IGT Devices Undivided$3,680
- IGT D Peripheral$842
- Senza$832
- (6554) Peripheral Vascular Undivided$522
- Turbo Elite$394
- Azur CX Detachable$239
- ABSOLUTE PRO$167
- Indigo System$147
- CONCERTOTM$134
- (5028) IGT D Systems Und$132
- S.M.A.R.T. CONTROL$120
- METACROSS OTW$119
- (5027) Intact Vascular Und$118
- OBSIDIO$111
- IV Other$107
- FlowTriever$102
- ClotTriever$102
- Navicross$102
How this compares
$21,464 in reported general payments places this provider in the 75th percentile of 81 vascular & interventional radiology providers in Missouri.
See all vascular & interventional radiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 44 | $45,243 |
| EliquisApixaban | 43 | $34,950 |
| ClopidogrelClopidogrel Bisulfate | 206 | $2,058 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $93 | $45,24344 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 81 vascular & interventional radiology providers in Missouri.
Other vascular & interventional radiology in Saint Louis
- Thomas VeselySaint Louis$852K
- Labib HaddadSaint Louis$643K
- Guillermo Gonzalez-AraizaSaint Louis$384K
- Pavan KavaliSaint Louis$90K
- Michael DarcySaint Louis$87K
- Steven SaukSaint Louis$68K
- Kurtis MauerSaint Louis$59K
- Suchit PatelSaint Louis$54K
- John KarageorgiouSaint Louis$44K
- Andrew WarrenSaint Louis$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.